首页>
外国专利>
Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy
Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy
展开▼
机译:HER-2 / neu过表达的癌细胞对化疗的敏感性
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to methods for the inhibition, of the gene product of the neu oncogene, p185neu tyrosine kinase. Over-expression of the neu oncogene leads to chemoresistance. The methods disclosed involve the novel use of E1A and/or LT in combination with chemotherapeutic drugs to treat carcinoma. Furthermore, E1A surprisingly potentiates the antineoplastic effects of the chemotherapeutic agents. The inventors propose that E1A sensitizes cancer cells such that they become amenable to treatment by chemotherapeutic drugs.
展开▼